Pharming Group NV

PHAR:NASDAQ
RT Quote | NASDAQ | USD
Last | 4:00 PM EST
14.60quote price arrow down-0.08 (-0.55%)
Volume
2,991
52 week range
14.08 - 21.99

...

Loading . . .

KEY STATS

  • Open14.69
  • Day High14.70
  • Day Low14.45
  • Prev Close14.68
  • 52 Week High21.99
  • 52 Week High Date12/23/20
  • 52 Week Low14.08
  • 52 Week Low Date12/29/20
  • Market Cap922.32M
  • Shares Out638.06M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Pharming Group NV News

There is no recent news for this security.

Latest PHAR News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1...
Jeroen Wakkerman
Chief Financial Officer
Address
Darwinweg 24
Leiden
2333 CR
Netherlands